Hannah M Cherniawsky

4PUBLICATIONS
4CO-AUTHORS
AutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 29, 2024
Ocular adverse events following CAR-T cell therapy: A pharmacovigilance study and systematic review.

Connor Frey, Hannah Cherniawsky, Mahyar Etminan

|Jun 15, 2021
Retrospective study of treatment patterns and outcomes post-lenalidomide for multiple myeloma in Canada.

Donna E Reece, Esther Masih-Khan, Ehetu G Atenafu

|Feb 04, 2021
The impact of lenalidomide maintenance on second-line chemotherapy in transplant eligible patients with multiple myeloma.

Hannah M Cherniawsky, Vishal Kukreti, Donna Reece

Pageof 1